Enabling Global Access to Lifesaving Therapeutics

Using artificial intelligence, Just Evotec Biologics has developed jHAL, a library of billions of fully human antibodies. The power of using machine learning instead of conventional random selection and testing is that antibody function can be intentionally tailored to meet any requirement, including targeting specific causes of disease and making them cheap and easy to manufacture. This breakthrough promises to vastly reduce the cost of lifesaving therapeutics while speeding up their rate of discovery, potentially making them universally accessible.